Barrington Research Forecasts Strong Price Appreciation for HealthEquity (NASDAQ:HQY) Stock

HealthEquity (NASDAQ:HQY) had its price objective boosted by research analysts at Barrington Research from $105.00 to $120.00 in a research note issued to investors on Monday,Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research’s target price suggests a potential upside of 18.18% from the stock’s current price.

A number of other research analysts have also issued reports on HQY. BTIG Research raised their target price on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research note on Thursday, November 14th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. Bank of America boosted their price objective on HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research report on Wednesday, November 13th. JMP Securities reaffirmed a “market outperform” rating and issued a $105.00 target price on shares of HealthEquity in a report on Wednesday, September 4th. Finally, Deutsche Bank Aktiengesellschaft upped their price target on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a report on Wednesday, September 4th. One research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $108.38.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $101.54 on Monday. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The stock has a market capitalization of $8.87 billion, a P/E ratio of 84.62, a P/E/G ratio of 1.59 and a beta of 0.52. The business has a 50-day moving average of $90.16 and a two-hundred day moving average of $82.85. HealthEquity has a fifty-two week low of $62.10 and a fifty-two week high of $105.82.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.50 by $0.16. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. The firm had revenue of $299.93 million during the quarter, compared to analysts’ expectations of $284.48 million. On average, equities research analysts predict that HealthEquity will post 2.27 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Frank Corvino sold 1,247 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total transaction of $100,084.22. Following the completion of the sale, the director now owns 4,823 shares in the company, valued at $387,093.98. This trade represents a 20.54 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the completion of the transaction, the director now directly owns 54,719 shares in the company, valued at $4,540,582.62. The trade was a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 10,536 shares of company stock valued at $884,517 over the last ninety days. 2.20% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. International Assets Investment Management LLC bought a new position in HealthEquity in the 2nd quarter worth approximately $35,000. Paladin Wealth LLC bought a new position in shares of HealthEquity in the 3rd quarter valued at about $39,000. GAMMA Investing LLC grew its position in shares of HealthEquity by 114.8% during the 2nd quarter. GAMMA Investing LLC now owns 595 shares of the company’s stock worth $51,000 after buying an additional 318 shares during the period. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of HealthEquity during the second quarter worth approximately $73,000. Finally, Quarry LP lifted its holdings in HealthEquity by 418.8% in the third quarter. Quarry LP now owns 1,349 shares of the company’s stock valued at $110,000 after buying an additional 1,089 shares during the period. Institutional investors and hedge funds own 99.55% of the company’s stock.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.